J. Chapman et al., ACE, MTHFR, FACTOR-V-LEIDEN, AND APOE POLYMORPHISMS IN PATIENTS WITH VASCULAR AND ALZHEIMERS DEMENTIA, Stroke, 29(7), 1998, pp. 1401-1404
Background and Purpose-There is a growing interest in the use of genet
ic markers in the differential diagnosis of dementia, In the current s
tudy we examined the usefulness of genetic risk factors for vascular d
isease as markers for vascular dementia (VD), Methods-The groups inclu
ded 41 patients with VD, 49 patients with dementia of the Alzheimer's
type, and 40 age-matched control subjects without dementia. These pati
ents were genotyped for vascular disease-associated polymorphisms in t
he genes coding for methylenetetrahydrofolate reductase (MTHFR), angio
tensin-converting enzyme (ACE), factor V Leiden (FVL), and a common ge
netic risk factor for AD, apolipoprotein E epsilon 4 (APOE epsilon 4).
Results-There was no significant association between ACE, MTHFR, and
FVL genotypes with VD whether compared with subjects with AD or with c
ontrol subjects. There was a higher frequency of APOE epsilon 4 allele
s in patients with AD (30%, P=0.016) and VD (26%, P=0.07) compared wit
h control subjects (15%), Conclusions-VD is not associated with the ge
netic risk factors for vascular disease examined in this study, indica
ting that the pathogenesis of VD may differ from other vascular diseas
es.